Successful treatment of extensively drug-resistant Acinetobacter baumannii ventriculitis with polymyxin B and tigecycline- a case report
Open Access
- 14 February 2018
- journal article
- case report
- Published by Springer Nature in Antimicrobial Resistance & Infection Control
- Vol. 7 (1) , 1-4
Abstract
Background: Acinetobacter baumannii nosocomial ventriculitis/meningitis, especially those due to drug-resistant strains, has substantially increased over recent years. However, limited therapeutic options exist for the Acinetobacter baumannii ventriculitis/meningitis because of the poor penetration rate of most antibiotics through the blood-brain barrier. Case presentation: A 57-year-old male patient developed ventriculitis from an extensively drug-resistant strain of Acinetobacter baumannii after the decompressive craniectomy for severe traumatic brain injury. The patient was successfully treated with intraventricular and intravenous polymyxin B together with intravenous tigecycline. Conclusions: The case illustrates intraventricular polymyxin B can be a therapeutic option against extensively drug-resistant Acinetobacter baumannii ventriculitis.Keywords
This publication has 12 references indexed in Scilit:
- First reported case of intraventricular tigecycline for meningitis from extremely drug-resistant Acinetobacter baumanniiJournal of Neurosurgery, 2017
- Polymyxin B versus colistin: an updateExpert Review of Anti-infective Therapy, 2015
- Intraventricular versus intravenous colistin for the treatment of extensively drug resistant Acinetobacter baumannii meningitisEuropean Journal of Neurology, 2015
- Cerebrospinal fluid penetration of tigecyclineScandinavian Journal of Infectious Diseases, 2013
- Intraventricular and intrathecal colistin as the last therapeutic resort for the treatment of multidrug-resistant and extensively drug-resistant Acinetobacter baumannii ventriculitis and meningitis: a literature reviewInternational Journal of Antimicrobial Agents, 2013
- Successful Management of Nosocomial Ventriculitis and Meningitis Caused by Extensively Drug‐Resistant Acinetobacter baumannii in AustriaCanadian Journal of Infectious Diseases and Medical Microbiology, 2013
- Intraventricular polymyxin B for the treatment of neonatal meningo-ventriculitis caused by multi-resistant Acinetobacter baumannii--case report and review of literatureThe Turkish Journal of Pediatrics, 2012
- Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistanceClinical Microbiology and Infection, 2012
- Current control and treatment of multidrug-resistant Acinetobacter baumannii infectionsThe Lancet Infectious Diseases, 2008
- TigecyclineJournal of Antimicrobial Chemotherapy, 2005